Strategic partnerships Enifer is actively forming collaborations with pet food and animal nutrition players (Rovio Pet Foods, Prima Pet/VAFO, Purina Unleashed accelerator) and exploring global expansion (US market) to commercialize PEKILO mycoprotein, presenting multiple co-development and private-label opportunities for protein ingredients and pet treats.

Pet nutrition focus Strong traction in animal nutrition with PEKILO mycoprotein, including a semi-moist dog treat launch and nutritional profiling (60% protein, meat-like amino acid profile), signaling a receptive segment for high-protein pet foods and functional treats.

Production scaling Plans for commercial-scale biomass fermentation facilities in Kantvik and another location in H2 2026 indicate rising supply capabilities, enabling larger-volume partnerships, white-label production, and regional supply agreements.

Regulatory and market readiness Active FDA review in the US and ongoing expansion in North America suggest near-term opportunities for manufacturers seeking stable high-protein and high-fiber ingredients, with potential pilot programs and feed trials aligned to regulatory timelines.

Sustainability edge Upcycling dilute food industry by-products into PEKILO mycoprotein positions Enifer as a sustainability-driven supplier, opening doors with ESG-focused brands, retailers, and index funds seeking greener protein ingredients and transparent supply chains.